Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted <sup>89</sup>Zr-Pertuzumab PET/CT
Gary A. Ulaner, Jorge A. Carrasquillo, Christopher C. Riedl, Randy Yeh, Vaios Hatzoglou, Dara S. Ross, Komal Jhaveri, Sarat Chandarlapaty, David M. Hyman, Brian M. Zeglis, Serge K. Lyashchenko, Jason S. Lewis
Abstract
See the editorial by Mankoff and Pantel in this issue.
Topics & Concepts
PertuzumabMedicineBreast cancerHuman Epidermal Growth Factor Receptor 2Metastatic breast cancerBiopsyCancerOncologyPrimary tumorInternal medicineRadiologyMetastasisPathologyHER2/EGFR in Cancer ResearchRadiopharmaceutical Chemistry and ApplicationsMedical Imaging Techniques and Applications